Literature DB >> 967200

Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

H J Alter, L B Seeff, P M Kaplan, V J McAuliffe, E C Wright, J L Gerin, R H Purcell, P V Holland, H J Zimmerman.   

Abstract

To determine the relation between the presence of donor DNA polymerase and e antigen, and recipient hepatitis, we tested, under code, serums from a controlled trial of hepatitis B immune globulin used to treat individuals accidentally inoculated with HBs Ag-positive blood. All recipients lacked antibody to HBs Ag. In 29 of 31 donors, both polymerase and e were in perfect agreement; both demonstrated a highly significant correlation with recipient hepatitis (P less than 0.001). DNA polymerase/e-negative blood did not cause hepatitis. Blood containing polymerase or e antigen did not cause hepatitis in six of 31 and four of 18 recipients, respectively. Hepatitis did not correlate with transaminase or duration of antigenemia in the donor. Polymerase and e appear to be indicators of the relative infectivity of HBs Ag-positive serum, particularly after small-volume exposure. They may be important determinants in assessing infectivity of chronic carriers of HBs Ag and in evaluating efficacy of hepatitis B immune globulin and hepatitis B vaccines.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 967200     DOI: 10.1056/NEJM197610212951701

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  52 in total

1.  Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers.

Authors:  Y Poovorawan; S Sanpavat; S Chumdermpadetsuk; A Safary
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

2.  Progress with hepatitis B virus-editorial review.

Authors:  W S Robinson
Journal:  West J Med       Date:  1978-02

3.  Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg).

Authors:  H E Blum; G Dölken; W Gerok
Journal:  Klin Wochenschr       Date:  1979-10-15

4.  Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.

Authors:  Adrian M Di Bisceglie; Wendy C King; Mauricio Lisker-Melman; Mandana Khalili; Steven H Belle; Jordan J Feld; Marc G Ghany; Harry L A Janssen; Daryl Lau; William M Lee; Simon C Ling; Stewart Cooper; Philip Rosenthal; Kathleen B Schwarz; Richard K Sterling; Jeffrey H Teckman; Norah Terrault
Journal:  J Viral Hepat       Date:  2019-05-02       Impact factor: 3.728

5.  Hepatitis B e-antigen and its correlation with other serological markers in chimpanzees.

Authors:  C M Ling; I K Mushahwar; L R Overby; K R Berquist; J E Maynard
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].

Authors:  B Stamm; W Gerlich; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-05-15       Impact factor: 3.402

7.  [Spread of hepatitis B virus infection among family contacts of asymptomatic HBsAg carriers (author's transl)].

Authors:  H H Dormeyer; G Hess; M Born; H Schönborn; W Arnold; J Knolle; B Zöller
Journal:  Klin Wochenschr       Date:  1979-12-03

8.  Detection of serum albumin receptor in hepatitis B virus carriers by enzyme-linked immunosorbent assay.

Authors:  T Tsuji
Journal:  Gastroenterol Jpn       Date:  1982-12

9.  HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

Authors:  R G Chadwick; M F Bassendine; E M Crawford; H C Thomas; S Sherlock
Journal:  Br Med J       Date:  1978-08-19

10.  Screening for hepatitis B virus in healthy blood donors by molecular DNA hybridization analysis.

Authors:  C F Sun; C C Pao; S Y Wu; Y F Liaw
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.